{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:44:50Z","timestamp":1794242690179,"version":"4.9.0"},"reference-count":123,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/01.med.0000433067.01671.f5","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T05:37:10Z","timestamp":1377236230000},"page":"377-388","source":"Crossref","is-referenced-by-count":67,"title":["A complications-based clinical staging of obesity to guide treatment modality and intensity"],"prefix":"10.1097","volume":"20","author":[{"given":"Sunil","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraneh","family":"Soleymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Timothy","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20211004","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4158\/EP12160.PS","article-title":"American Association of Clinical Endocrinologists position statement on obesity and obesity medicine.","volume":"18","author":"Mechanick","year":"2012","journal-title":"Endocr Pract"},{"key":"R2-4-20211004","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.psc.2011.07.002","article-title":"Medical and behavioral evaluation of patients with obesity.","volume":"34","author":"Kushner","year":"2011","journal-title":"Psychiatr Clin N Am"},{"key":"R3-4-20211004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999-2008.","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"key":"R4-4-20211004","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jama.2009.2012","article-title":"Prevalence of high body mass index in US children and adolescents, 2007-2008.","volume":"303","author":"Ogden","year":"2010","journal-title":"JAMA"},{"key":"R5-4-20211004","first-page":"51S","article-title":"Identification, Evaluation, and Treatment of Overweight and Obesity in AdultsClinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the evidence report.","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"R6-4-20211004","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1467-789X.2001.00040.x","article-title":"Quality of life and obesity.","volume":"2","author":"Kolotkin","year":"2001","journal-title":"Obes Rev"},{"key":"R7-4-20211004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diabres.2010.04.012","article-title":"The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies.","volume":"89","author":"Abdullah","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"R8-4-20211004","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1000367","article-title":"Body mass index and mortality among 1.46 million white adults.","volume":"363","author":"Berrington de Gonzalez","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-4-20211004","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/qjmed\/hcl085","article-title":"The medical complications of obesity.","volume":"99","author":"Malnick","year":"2006","journal-title":"Q J Med"},{"key":"R12-4-20211004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study GroupMulticenter, placebo-controlled trial of lorcaserin for weight management.","volume":"363","author":"Smith","year":"2010","journal-title":"N Engl J Med"},{"key":"R13-4-20211004","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1210\/jc.2011-1256","article-title":"BLOSSOM Clinical Trial GroupA one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.","volume":"96","author":"Fidler","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-4-20211004","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phenterminetopiramate in severely obese adults: a randomized controlled trial (EQUIP).","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity"},{"key":"R15-4-20211004","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial.","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"R16-4-20211004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events.","volume":"307","author":"Sjostrom","year":"2012","journal-title":"JAMA"},{"key":"R17-4-20211004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ndt\/gfm517","article-title":"Adolphe Quetelet (1796-1874): the average man and indices of obesity.","volume":"23","author":"Eknoyan","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R18-4-20211004","first-page":"1073","article-title":"Ann Intern M","volume":"103","year":"1985","journal-title":"ed"},{"key":"R20-4-20211004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/j.1550-8528.1996.tb00510.x","article-title":"Relationships between the body mass index and body composition.","volume":"4","author":"Wellens","year":"1996","journal-title":"Obes Res"},{"key":"R21-4-20211004","first-page":"307","article-title":"Does body mass index reflect adequately the body fat content in perimenopausal women M","volume":"51","author":"Kontogianni","year":"2005","journal-title":"aturitas"},{"key":"R22-4-20211004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1467-789x.2001.00031.x","article-title":"Beyond body mass index.","volume":"2","author":"Prentice","year":"2001","journal-title":"Obes Rev"},{"key":"R24-4-20211004","first-page":"137","article-title":"Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.","volume":"84","author":"Banerji","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-4-20211004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ijo.2010.5","article-title":"Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis.","volume":"34","author":"Okorodudu","year":"2010","journal-title":"Int J Obesity"},{"key":"R27-4-20211004","doi-asserted-by":"crossref","first-page":"580","DOI":"10.5694\/j.1326-5377.2003.tb05704.x","article-title":"Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia.","volume":"179","author":"Welborn","year":"2003","journal-title":"Med J Aust"},{"key":"R28-4-20211004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2337\/diacare.26.1.97","article-title":"Life course influences on insulin resistance: findings from the British Womens Heart and Health Study.","volume":"26","author":"Lawlor","year":"2003","journal-title":"Diabetes Care"},{"key":"R29-4-20211004","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1001\/archinte.162.18.2074","article-title":"Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines.","volume":"162","author":"Janssen","year":"2002","journal-title":"Arch Intern Med"},{"key":"R30-4-20211004","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2337\/diacare.27.4.978","article-title":"Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.","volume":"27","author":"Liao","year":"2004","journal-title":"Diabetes Care"},{"key":"R31-4-20211004","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1210\/jc.2004-0683","article-title":"Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach.","volume":"89","author":"Lara-Castro","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-4-20211004","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(11)60105-0","article-title":"Emerging Risk Factors CollaborationSeparate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.","volume":"377","author":"Wormser","year":"2011","journal-title":"Lancet"},{"key":"R33-4-20211004","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"key":"R34-4-20211004","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1210\/jc.2007-0334","article-title":"RISC InvestigatorsInsulin resistance, insulin response, and obesity as indicators of metabolic risk.","volume":"92","author":"Ferrannini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-4-20211004","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/oby.20431","article-title":"Lifestyle intervention andor statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study.","volume":"21","author":"Belalcazar","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"R36-4-20211004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Multicenter, placebo-controlled trial of lorcaserin for weight management.","volume":"363","author":"Smith","year":"2010","journal-title":"N Engl J Med"},{"key":"R37-4-20211004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phenterminetopiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"R38-4-20211004","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial.","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"R39-4-20211004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial.","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"key":"R40-4-20211004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/SLA.0b013e31827b6c02","article-title":"Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature.","volume":"257","author":"OBrien","year":"2013","journal-title":"Ann Surg"},{"key":"R41-4-20211004","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s11883-012-0286-4","article-title":"Gastrointestinal surgery: cardiovascular risk reduction and improved long-term survival in patients with obesity and diabetes.","volume":"14","author":"Adams","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"R42-4-20211004","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11883-012-0285-5","article-title":"Gastrointestinal surgery for obesity and diabetes: weight loss and control of hyperglycemia.","volume":"14","author":"Heneghan","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"R43-4-20211004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ijo.2009.2","article-title":"A proposed clinical staging system for obesity.","volume":"33","author":"Sharma","year":"2009","journal-title":"Int J Obesity"},{"key":"R45-4-20211004","doi-asserted-by":"crossref","first-page":"E1059","DOI":"10.1503\/cmaj.110387","article-title":"Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity.","volume":"183","author":"Padwal","year":"2011","journal-title":"CMAJ"},{"key":"R47-4-20211004","first-page":"327","article-title":"American Association of Clinical Endocrinologists. AACE Comprehensive Diabetes Management Algorithm.","volume":"19","author":"Garber","year":"2013","journal-title":"Endocr Pract"},{"key":"R48-4-20211004","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1161\/01.CIR.0000145546.97738.1E","article-title":"Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.","volume":"110","author":"Klein","year":"2004","journal-title":"Circulation"},{"key":"R49-4-20211004","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archinte.167.9.875","article-title":"Obesity and mortality: watch your waist, not just your weight.","volume":"167","author":"Hu","year":"2007","journal-title":"Arch Intern Med"},{"key":"R50-4-20211004","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R51-4-20211004","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.diabres.2009.11.010","article-title":"Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.","volume":"87","author":"Hadaegh","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"R52-4-20211004","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes.","volume":"112","author":"Wilson","year":"2005","journal-title":"Circulation"},{"key":"R53-4-20211004","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"R54-4-20211004","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.2337\/diacare.26.11.3153","article-title":"San Antonio Heart StudyThe metabolic syndrome as a predictor of type 2 diabetes: the San Antonio Heart Study.","volume":"26","author":"Lorenzo","year":"2003","journal-title":"Diabetes Care"},{"key":"R55-4-20211004","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/jama.285.16.2109","article-title":"Relation of impaired fasting glucose and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study.","volume":"285","author":"de Vegt","year":"2011","journal-title":"JAMA"},{"key":"R56-4-20211004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"R58-4-20211004","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"R59-4-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and natural history of NAFLD and NASH.","volume":"11","author":"Ong","year":"2007","journal-title":"Clin Liver Dis"},{"key":"R60-4-20211004","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States.","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R61-4-20211004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/gast.2003.50004","article-title":"Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.","volume":"124","author":"Ruhl","year":"2003","journal-title":"Gastroenterology"},{"key":"R62-4-20211004","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease.","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"key":"R63-4-20211004","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"R64-4-20211004","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1381\/0960892053576820","article-title":"Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.","volume":"15","author":"Ong","year":"2005","journal-title":"Obes Surg"},{"key":"R66-4-20211004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"R67-4-20211004","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"R68-4-20211004","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"R69-4-20211004","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1381\/096089206777346682","article-title":"Change in liver size and fat content after treatment with Optifast very low calorie diet.","volume":"16","author":"Lewis","year":"2006","journal-title":"Obes Surg"},{"key":"R70-4-20211004","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.3748\/wjg.v12.i36.5813","article-title":"Effect of nutritional counseling on hepatic, muscle and adipose tissue fat content and distribution in nonalcoholic fatty liver disease.","volume":"12","author":"Thomas","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R71-4-20211004","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/oby.2008.201","article-title":"Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.","volume":"16","author":"Larson-Meyer","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"R72-4-20211004","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2036.2004.02153.x","article-title":"A pilot study of orlistat treatment in obese, nonalcoholic steatohepatitis patients.","volume":"20","author":"Harrison","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R73-4-20211004","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.2006.106021","article-title":"Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis.","volume":"56","author":"Assy","year":"2007","journal-title":"Gut"},{"key":"R74-4-20211004","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cgh.2006.02.004","article-title":"A double-blind randomized placebo-controlled trial of orlistat for treatment of nonalcoholic fatty liver disease.","volume":"4","author":"Zelber-Sagi","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R75-4-20211004","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1572-0241.2006.00419.x","article-title":"Nonalcoholic steatohepatitis: effect of roux-en-Y gastric bypass surgery.","volume":"101","author":"Barker","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R76-4-20211004","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11695-007-9086-2","article-title":"Resolution of nonalcoholic steatohepatitis after gastric bypass surgery.","volume":"17","author":"Liu","year":"2007","journal-title":"Obes Surg"},{"key":"R77-4-20211004","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/sleep\/20.9.705","article-title":"Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women.","volume":"20","author":"Young","year":"1997","journal-title":"Sleep"},{"key":"R78-4-20211004","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.284.23.3015","article-title":"Longitudinal study of moderate weight change and sleep-disordered breathing.","volume":"284","author":"Peppard","year":"2000","journal-title":"JAMA"},{"key":"R79-4-20211004","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2337\/dc08-1776","article-title":"Sleep AHEAD Research GroupObstructive sleep apnea among obese patients with type 2 diabetes.","volume":"32","author":"Foster","year":"2009","journal-title":"Diabetes Care"},{"key":"R80-4-20211004","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.2109080","article-title":"Epidemiology of obstructive sleep apnea. A population health perspective.","volume":"165","author":"Young","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R81-4-20211004","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1164\/rccm.200805-669OC","article-title":"Kuopio Sleep Apnea GroupLifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea.","volume":"179","author":"Tuomilehto","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R82-4-20211004","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1001\/archinternmed.2009.266","article-title":"for the Sleep AHEAD Research Group of the Look AHEAD Research GroupA randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study.","volume":"169","author":"Foster","year":"2009","journal-title":"Arch Intern Med"},{"key":"R83-4-20211004","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5665\/sleep.2618","article-title":"Sleep AHEAD Research Group of the Look AHEAD Research GroupLong-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes.","volume":"36","author":"Kuna","year":"2013","journal-title":"Sleep"},{"key":"R84-4-20211004","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1159\/000107736","article-title":"Bariatric surgery in the treatment of obstructive sleep apnea in morbidly obese patients.","volume":"74","author":"Fritscher","year":"2007","journal-title":"Respiration"},{"key":"R85-4-20211004","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.5665\/sleep.2204","article-title":"A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phenterminetopiramate for the treatment of obstructive sleep apnea in obese adults.","volume":"35","author":"Winslow","year":"2012","journal-title":"Sleep"},{"key":"R86-4-20211004","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","article-title":"Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.","volume":"143","author":"Hampel","year":"2005","journal-title":"Ann Intern Med"},{"key":"R87-4-20211004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/gut.43.3.327","article-title":"Opposing time trends of peptic ulcer and reflux disease.","volume":"43","author":"El-Serag","year":"1998","journal-title":"Gut"},{"key":"R88-4-20211004","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/oby.20279","article-title":"Mandeep, Lee Jaehoon, Gupta Neil, et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial.","volume":"21","year":"2013","journal-title":"Obesity"},{"key":"R89-4-20211004","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11695-011-0540-9","article-title":"Gastroesophageal reflux after vertical banded gastroplasty is alleviated by conversion to gastric bypass.","volume":"22","author":"Ekelund","year":"2012","journal-title":"Obes Surg"},{"key":"R90-4-20211004","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11894-011-0191-y","article-title":"Obesity and GERD: pathophysiology and effect of bariatric surgery (review).","volume":"13","author":"Tutuian","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"key":"R91-4-20211004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1185\/03007995.2012.666962","article-title":"Effect of adjustable gastric banding on changes in gastroesophageal reflux disease (GERD) and quality of life.","volume":"28","author":"Woodman","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"R92-4-20211004","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2010.03.001","article-title":"Epidemiology of osteoarthritis.","volume":"26","author":"Zhang","year":"2010","journal-title":"Clin Geriatr Med"},{"key":"R94-4-20211004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-109-1-18","article-title":"Obesity and knee osteoarthritis. The Framingham Study.","volume":"109","author":"Felson","year":"1988","journal-title":"Ann Intern Med"},{"key":"R95-4-20211004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.joca.2004.10.008","article-title":"Weight loss: the treatment of choice for knee osteoarthritis A randomized trial.","volume":"13","author":"Christensen","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"R96-4-20211004","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/0003-4819-116-7-535","article-title":"Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study.","volume":"116","author":"Felson","year":"1992","journal-title":"Ann Intern Med"},{"key":"R97-4-20211004","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/ard.2006.065904","article-title":"Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis.","volume":"66","author":"Christensen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R98-4-20211004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diabres.2010.04.012","article-title":"The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies.","volume":"89","author":"Abdullah","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"R99-4-20211004","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R100-4-20211004","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome.","volume":"13","author":"Norman","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"R101-4-20211004","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome.","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obesity"},{"key":"R102-4-20211004","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.fertnstert.2007.04.043","article-title":"Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.","volume":"89","author":"Panidis","year":"2008","journal-title":"Fertil Steril"},{"key":"R103-4-20211004","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.AOG.0000285483.22898.9c","article-title":"Changes in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women.","volume":"110","author":"Burgio","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R104-4-20211004","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMoa0806375","article-title":"Weight loss to treat urinary incontinence in overweight and obese women.","volume":"360","author":"Subak","year":"2009","journal-title":"N Engl J Med"},{"key":"R105-4-20211004","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"R106-4-20211004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.2012.06750.x","article-title":"Obesity and cancer risk: evidence, mechanisms, and recommendations.","volume":"1271","author":"Vucenik","year":"2012","journal-title":"Ann NY Acad Sci"},{"key":"R107-4-20211004","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM199603283341306","article-title":"Assessment of quality of life outcomes.","volume":"334","author":"Testa","year":"1996","journal-title":"N Engl J Med"},{"key":"R108-4-20211004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00115677-199803020-00002","article-title":"Estimating health-related quality of life in obese individuals.","volume":"3","author":"Fontaine","year":"1998","journal-title":"Dis Manage Health Outcomes"},{"key":"R109-4-20211004","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0899-9007(00)00404-4","article-title":"Obesity and quality of life.","volume":"16","author":"Kushner","year":"2000","journal-title":"Nutrition"},{"key":"R110-4-20211004","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1467-789X.2009.00612.x","article-title":"A systematic review of the quality of psychometric evidence supporting the use of an obesity-specific quality of life measure for use with persons who have class III obesity.","volume":"11","author":"Forhan","year":"2010","journal-title":"Obes Rev"},{"key":"R111-4-20211004","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.ijo.0800553","article-title":"Swedish obese subjects (SOS): an intervention study of obesity. Two-year-follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity.","volume":"22","author":"Karlsson","year":"1998","journal-title":"Int J Obesity Rel Metab Disord"},{"key":"R112-4-20211004","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.ijo.0800890","article-title":"Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study.","volume":"23","author":"Narbro","year":"1999","journal-title":"Int J Obesity Rel Metab Disord"},{"key":"R113-4-20211004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1072-7515(99)00030-7","article-title":"A health status assessment of the impact of weight loss following roux-en-Y gastric bypass for clinically severe obesity.","volume":"188","author":"Choban","year":"1999","journal-title":"J Am Coll Surg"},{"key":"R114-4-20211004","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ajcn\/67.2.197","article-title":"Quality of life assessment of morbidly obese patients: effect of weight-reducing surgery.","volume":"67","author":"van Gemert","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"R115-4-20211004","first-page":"875","article-title":"Effect of moderate weight loss on health-related quality of life: an analysis of combined data from 4 randomized trials of sibutramine vs placebo.","volume":"7","author":"Samsa","year":"2001","journal-title":"Am J Manag Care"},{"key":"R116-4-20211004","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/archinte.160.14.2185","article-title":"Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.","volume":"160","author":"McMahon","year":"2000","journal-title":"Arch Intern Med"},{"key":"R117-4-20211004","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0306-4603(95)00081-X","article-title":"Depression, smoking, activity level, and health status: pretreatment predictors of attrition in obesity treatment.","volume":"21","author":"Clark","year":"1996","journal-title":"Addict Behav"},{"key":"R118-4-20211004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1139\/H07-023","article-title":"Strategies to enhance compliance to physical activity for patients with insulin resistance.","volume":"32","author":"Kirk","year":"2007","journal-title":"Appl Physiol Nutr Metab"},{"key":"R119-4-20211004","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/sj.ijo.0802727","article-title":"Pretreatment predictors of attrition and successful weight management in women.","volume":"28","author":"Teixeira","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R120-4-20211004","first-page":"503","article-title":"Swedish Obese Subjects (SOS): an intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined.","volume":"17","author":"Sullivan","year":"1993","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R121-4-20211004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/qjmed\/hcl041","article-title":"Psychiatric co-morbidities in patients attending specialist obesity services in the UK.","volume":"99","author":"Tuthill","year":"2006","journal-title":"QJM"},{"key":"R122-4-20211004","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.ijo.0801449","article-title":"Rates of psychiatric disorders in a clinical study group of adolescents with extreme obesity and in obese adolescents ascertained via a population based study.","volume":"24","author":"Britz","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R123-4-20211004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/ajp.149.2.227","article-title":"Prevalence of mental disorder in 88 morbidly obese bariatric clinic patients.","volume":"149","author":"Black","year":"1992","journal-title":"Am J Psychiatry"},{"key":"R124-4-20211004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000226278","article-title":"Depression and anxiety: their predictive function for weight loss in obese individuals.","volume":"2","author":"Legenbauer","year":"2009","journal-title":"Obes Facts"},{"key":"R125-4-20211004","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/obr.12017","article-title":"Food-related impulsivity in obesity and binge eating disorder: a systematic review.","volume":"14","author":"Schag","year":"2013","journal-title":"Obes Rev"},{"key":"R126-4-20211004","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00115-010-3225-z","article-title":"Diagnostic criteria for eating disorders: what will DSM-5 feature N","volume":"82","author":"de Zwaan","year":"2011","journal-title":"ervenarzt"},{"key":"R128-4-20211004","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1037\/a0025049","article-title":"Cognitive-behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: a randomized controlled trial.","volume":"79","author":"Grilo","year":"2011","journal-title":"J Consult Clin Psychol"},{"key":"R129-4-20211004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/eat.20370","article-title":"Binge eating disorder treatment: a systematic review of randomized controlled trials.","volume":"40","author":"Brownley","year":"2007","journal-title":"Int J Eat Disord"},{"key":"R130-4-20211004","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","article-title":"DPP): description of lifestyle intervention.","volume":"25","year":"2002","journal-title":"Diabetes Care"},{"key":"R131-4-20211004","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/oby.2006.84","article-title":"AHEAD study: a description of the lifestyle intervention and the evidence supporting it.","volume":"14","year":"2006","journal-title":"Obesity"},{"key":"R132-4-20211004","first-page":"893","article-title":"Why do we need drugs to treat the patient with obesity O","volume":"21","author":"Bray","year":"2013","journal-title":"besity"},{"key":"R133-4-20211004","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.mcna.2011.06.010","article-title":"Surgical approaches to the treatment of obesity: bariatric surgery.","volume":"95","author":"Smith","year":"2011","journal-title":"Med Clin N Am"},{"key":"R134-4-20211004","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Look AHEAD Research GroupBenefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01266029-201310000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:11Z","timestamp":1786047971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01266029-201310000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":123,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/01.med.0000433067.01671.f5","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}